Back to search

Article

Improving Motor Function in Amyotrophic Lateral Sclerosis: The impact of Triumeq on a TDP-43 mouse model

2025-09-03

Abstract excerpt

<title>Abstract</title> <p>Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by the accumulation of TAR DNA Binding Protein (43kDa; TDP-43) within the cytoplasm of neurons. Endogenous retroviruses (ERVs) have been implicated in ALS pathology and the application of antiretroviral therapy, specifically Triumeq, has been proposed for treatment of ALS. However, evidenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
15cf28da-95c6-5d8f-992f-486b74c1242a
DOI
10.21203/rs.3.rs-7351593/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improving Motor Function in Amyotrophic Lateral Sclerosis: The impact of Triumeq on a TDP-43 mouse modelDOI 10.21203/rs.3.rs-7351593/v1
Select a neighboring publication to make it the new centre.